Hyperbaric medicine
Hyperbaric medicine is the branch of medicine in which clinical therapies are delivered in pressurized vessels containing prescribed barometric pressures of gases such as air or oxygen.
≈ 16 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Hyperbaric medicine is the branch of medicine in which clinical therapies are delivered in pressurized vessels containing prescribed barometric pressures of gases such as air or oxygen. The immediate effects include reducing the size of gas emboli and raising the partial pressures of the gases present.
Initial uses were in decompression sickness, and it is also effective in certain cases of gas gangrene and carbon monoxide poisoning. There are risks associated with hyperbaric therapy, including barotrauma, and, if pure oxygen is used, a fire hazard.
Hyperbaric oxygen therapy (HBOT) is the medical use of greater than 99% oxygen at an ambient pressure higher than atmospheric pressure, and therapeutic recompression. The equipment required consists of a pressure vessel for human occupancy (hyperbaric chamber), which may be of rigid or flexible construction, and a means of a controlled atmosphere supply.
Treatment gas may be the ambient chamber gas, or delivered via a built-in breathing system. Operation is performed to a predetermined schedule by personnel who may adjust the schedule as required. Hyperbaric air (HBA) consists of compressed atmospheric air (79% nitrogen, 21% oxygen, and minor gases) and is used for acute mountain sickness.…
Hyperbaric medicine is the branch of medicine in which clinical therapies are delivered in pressurized vessels containing prescribed barometric pressures of gases such as air or oxygen. The immediate effects include reducing the size of gas emboli and raising the partial pressures of the gases present.
Initial uses were in decompression sickness, and it is also effective in certain cases of gas gangrene and carbon monoxide poisoning. There are risks associated with hyperbaric therapy, including barotrauma, and, if pure oxygen is used, a fire hazard.
Hyperbaric oxygen therapy (HBOT) is the medical use of greater than 99% oxygen at an ambient pressure higher than atmospheric pressure, and therapeutic recompression. The equipment required consists of a pressure vessel for human occupancy (hyperbaric chamber), which may be of rigid or flexible construction, and a means of a controlled atmosphere supply.
Treatment gas may be the ambient chamber gas, or delivered via a built-in breathing system. Operation is performed to a predetermined schedule by personnel who may adjust the schedule as required. Hyperbaric air (HBA) consists of compressed atmospheric air (79% nitrogen, 21% oxygen, and minor gases) and is used for acute mountain sickness.
This is applied by placing the person in a portable hyperbaric air chamber and inflating that chamber up to using a foot-operated or electric air pump. Chambers used in the US made for hyperbaric medicine fall under the jurisdiction of the federal Food and Drug Administration (FDA).
The FDA requires hyperbaric chambers to comply with the American Society of Mechanical Engineers PVHO Codes and the National Fire Protection Association Standard 99, Health Care Facilities Code. Similar conditions apply in most other countries. Other uses include arterial gas embolism caused by pulmonary barotrauma of ascent.
In emergencies divers may sometimes be treated by in-water recompression (when a chamber is not available) if suitable diving equipment (to reasonably secure the airway) is available.
Scope
Hyperbaric medicine includes hyperbaric oxygen treatment, which is the medical use of oxygen at greater than atmospheric pressure to increase the availability of oxygen in the body; and therapeutic recompression, which involves increasing the ambient pressure on a person, usually a diver, to treat decompression sickness or an air embolism by reducing the volume and more rapidly eliminating bubbles that have formed within the body.
Medical uses
The Undersea and Hyperbaric Medical Society (UHMS) lists 15 supported uses as of 2025: Air or gas embolism; Carbon monoxide poisoning including that complicated by cyanide poisoning; Clostridal myositis and myonecrosis (gas gangrene); Crush injury, compartment syndrome, and other acute traumatic ischemias; Decompression sickness; Central retinal artery occlusion and enhancement of healing in selected problem wounds due to insufficient arterial blood flow, including the diabetic foot; Exceptional blood loss (anemia); Intracranial abscess; Necrotizing soft tissue infections (necrotizing fasciitis); Osteomyelitis (refractory); Delayed radiation injury (soft tissue and bony necrosis); Skin grafts and flaps (compromised); Thermal burns (early); Idiopathic sudden sensorineural hearing loss; Avascular necrosis These uses are similar to those approved by the US FDA as of 2021. Mucormycosis, especially rhinocerebral disease in the setting of diabetes mellitus may be supported.
Treatment efficacy of HBOT for most of these conditions is based on testing at 2–3 bar (atmospheres of pressure) , but it is also marketed at lower pressures (and lower costs) despite lack of evidence of efficacy. There is insufficient evidence for use in autism, cancer, diabetes, HIV/AIDS, Alzheimer's, asthma, Bell's palsy, cerebral palsy, depression, heart disease, migraines, multiple sclerosis, Parkinson's, spinal cord injury, sports injuries, or stroke.
Furthermore, potential side effects pose an unjustified risk in such cases. A 2016 meta-analysis found no evidence of improvements in social abilities or cognitive functioning in autistic individuals treated with HBOT.
The paper also noted conducting further trials would be ethically fraught, as studies had not revealed efficacy, but documented that HBOT can cause minor-grade ear barotrauma events. Despite the lack of evidence of benefit, in 2015, the number of people utilizing this therapy has continued to rise.
There is also insufficient evidence to support its use in acute traumatic or surgical wounds.
Migraines
Low-quality evidence suggests it may reduce pain in an ongoing migraine headache. It is not known which people would benefit from this treatment, and there is no evidence that it prevents future migraines.
Side effects
Oxygen toxicity is a limitation on both maximum partial pressure of oxygen, and on length of each treatment. A 2023 review found that negative outcomes (predominantly mild barotrauma (air pressure effect on ear or lung) that could be resolved spontaneously) were experienced by 24% of patients, but they were not prevented from completing the treatment regimen, and no serious side effects, complications or deaths were reported.
Complications
There are risks associated with HBOT, similar to some diving disorders. Pressure changes can cause a "squeeze" or barotrauma in the tissues surrounding trapped air inside the body, such as the lungs, behind the eardrum, inside paranasal sinuses, or trapped underneath dental fillings. Breathing high-pressure oxygen may cause oxygen toxicity.
Temporarily blurred vision can be caused by swelling of the lens, which usually resolves in two to four weeks. HBOT can accelerate the development of cataracts over multiple repetitive treatments. There are reports that cataracts may progress following HBOT, and rarely, may develop de novo, but this may be unrecognized and under reported.
The cause is not fully explained, but evidence suggests that lifetime exposure of the lens to high partial pressure oxygen may be a major factor. Oxidative damage to lens proteins is thought to be responsible. This may be an end-stage of the relatively well documented "myopic shift" detected in most hyperbaric patients after a course of multiple treatments.
Mechanism of action
The therapeutic consequences of HBOT and recompression result from multiple effects.
Pressure
The increased overall pressure is of therapeutic value in the treatment of decompression sickness and air embolism as it provides a physical means of reducing the volume of inert gas bubbles within the body; Exposure to this increased pressure is maintained for a period long enough to ensure that most of the bubble gas is dissolved back into the tissues, removed by perfusion and eliminated in the lungs. The improved concentration gradient for inert gas elimination (oxygen window) by using a high partial pressure of oxygen increases the rate of inert gas elimination in the treatment of decompression sickness.
For many other conditions, the therapeutic principle of HBOT lies in its ability to drastically increase partial pressure of oxygen in the tissues of the body. The oxygen partial pressures achievable using HBOT are much higher than those achievable while breathing pure oxygen under normobaric conditions (i.e. at normal atmospheric pressure).
This effect is achieved by an increase in the oxygen transport capacity of the blood. At normal atmospheric pressure, oxygen transport is limited by the oxygen binding capacity of hemoglobin in red blood cells and very little oxygen is transported by blood plasma.
Because the hemoglobin of the red blood cells is almost saturated with oxygen at atmospheric pressure, this route of transport cannot be exploited any further. Oxygen transport by plasma, however, is significantly increased using HBOT because of the higher solubility of oxygen as pressure increases.
Construction
The traditional type of hyperbaric chamber used for therapeutic recompression and HBOT is a rigid shelled pressure vessel. Such chambers can be run at absolute pressures typically about , or more in special cases. Navies, professional diving organizations, hospitals, and dedicated recompression facilities typically operate these.
They range in size from semi-portable, one-patient units to room-sized units that can treat eight or more patients. The larger units may be rated for lower pressures if they are not primarily intended for treatment of diving injuries.
A rigid chamber may consist of: a pressure vessel designed to a code such as ASME Boiler and Pressure Vessel Code viewports to allow the medical personnel to visually monitor the occupants, and can be used for hand signaling as an auxiliary emergency communications method. The major components are the window (transparent acrylic), the window seat (holds the acrylic window), and retaining ring.
Interior lighting can be provided by mounting lights outside the viewports. Viewports are a feature specific to PVHOs due to the need to see the people inside and evaluate their health. Other materials have been attempted, but they consistently fail to maintain their seal or have cracks which would progress rapidly to catastrophic failure.
Acrylic is more likely to have small cracks the operators can see and have time to take mitigation steps instead of failing catastrophically. Counterfeit chambers often do not use acrylic windows. one or more human entry hatches small and circular or wheel-in type hatches for patients on gurneys; the entry lock that allows human entry a separate chamber with two hatches, one to the outside and one to the main chamber, which can be independently pressurized to allow patients to enter or exit the main chamber while it is still pressurized; a low volume medical or service airlock for medicines, instruments, and food; transparent ports or closed-circuit television that allows technicians and medical staff outside the chamber to monitor the patient inside the chamber; an intercom system allowing two-way communication; an optional carbon dioxide scrubber consisting of a fan that passes the gas inside the chamber through a soda lime canister; a control panel outside the chamber to open and close valves that control air flow to and from the chamber, and regulate oxygen to hoods or masks; an over-pressure relief valve; a built-in breathing system (BIBS) to supply and exhaust treatment gas; a fire suppression system.
Flexible monoplace chambers are available ranging from collapsible flexible aramid fiber-reinforced chambers which can be disassembled for transport via truck or SUV, with a maximum working pressure of 2 bar above ambient complete with BIBS allowing full oxygen treatment schedules. to portable, air inflated "soft" chambers that can operate at between above atmospheric pressure with no supplemental oxygen, and longitudinal zipper closure.
Viewports
Acrylic windows with PVHO-1 defined standard geometries and design criteria are generally used. Shapes and sizes vary with chamber application and the requirements for the specific use.
The geometries in general use include: Flat circular windows (low pressure) Conical edged windows with flat inner and outer faces (high pressure on one side only) Circular windows with double beveled edges Light pipes Low pressure, small diameter chambers may use large cylindrical windows fitted inside the metal structure. In some cases the whole cylindrical pressure chamber has been made from an acrylic tube.
The acrylic windows of a hyperbaric chamber have a limited lifespan, which can be expressed as the design life, which is the conservatively estimated life as calculated in the design process, typically about 10 years, and the service life, which is the actual time the window can be safely and legally used when well maintained, properly inspected, and repaired when necessary and possible and which can be as much as twice the design life. There are three grades of inspection required: Operational inspection of the inner and outer surfaces is included in the checks before first pressurisation of the day by a competent chamber operator, and ensures that the surfaces have not been damaged since the last use.
Maintenance inspection is done at specified intervals by a qualified maintenance inspector. This inspection is more thorough and may require removal of the window from the mounting to check for damage that is not visible when installed. This grade of inspection is generally also required for re-commissioning a chamber that has been out of service for longer than a specified period.
Seat and seal inspection is done whenever a window has been removed for inspection or repair or a new window installed. The window is examined to detect crazing, cracks, blisters, discolouration, scratches or pits.
Operating pressures
The operating pressure depends on the application. Chambers used for clinical hyperbaric oxygen therapy commonly have a maximum allowable working pressure of with a maximum of about Chambers used for support of commercial or military diving operations and for research may have a maximum allowable working pressure of up to .
Personnel
Diving medical practitioner – a specialist in diving medicine Chamber operator – a person competent to operate a hyperbaric chamber Hyperbaric nurse – a nurse responsible for administering hyperbaric oxygen therapy to patients and supervising them throughout the treatment. Diving medical technician – member of a dive team who is trained in advanced first aid.
Hyperbaric medical practitioner – a specialist in hyperbaric medicine Chamber attendant – a person trained in basic first aid who is medically fit to dive in a chamber, usually a member of a diving team allocated to looking after the diver being treated.
Hyperbaric air
A British physician, Nathaniel Henshaw, proposed what would have been the first hyperbaric chamber for medical treatment of humans in 1662. The container was to have been pressurised with air, which at the time was not yet known to contain oxygen, later discovered by Carl Wilhelm Scheele around 1770 and first published by Joseph Priestley in 17751, or carbon dioxide.
Although it is widely accepted that the chamber was built and used, there are inconsistencies in the description of the engineering details of construction and use that make it very unlikely that it would have been able to seal or withstand the forces involved, and the procedures described would have been hazardous. Victot T. Junod built a chamber in France in 1834 to treat pulmonary conditions at pressures between 2 and 4 atmospheres absolute.
During the following century "pneumatic centres" were established in Europe and the USA which used hyperbaric air to treat a variety of conditions. Orval J Cunningham, a professor of anesthesia at the University of Kansas in the early 1900s observed that people with circulatory disorders did better at sea level than at altitude and this formed the basis for his use of hyperbaric air.
In 1918, he successfully treated patients with the Spanish flu with hyperbaric air. In 1930 the American Medical Association forced him to stop hyperbaric treatment, since he did not provide acceptable evidence that the treatments were effective.
Hyperbaric oxygen
The English scientist Joseph Priestley discovered oxygen in 1775. Shortly after its discovery, there were reports of toxic effects of hyperbaric oxygen on the central nervous system and lungs, which delayed therapeutic applications until 1937, when Behnke and Shaw first used it in the treatment of decompression sickness.
In 1955 and 1956 Churchill-Davidson, in the UK, used hyperbaric oxygen to enhance the radiosensitivity of tumours, while , at the University of Amsterdam, successfully used it in cardiac surgery. In 1961 et al. published on the use of hyperbaric oxygen in the treatment of clostridial gas gangrene.
In 1962 Smith and Sharp reported successful treatment of carbon monoxide poisoning with hyperbaric oxygen. The Undersea Medical Society (now Undersea and Hyperbaric Medical Society) formed a Committee on Hyperbaric Oxygenation which has become recognized as the authority on indications for hyperbaric oxygen treatment.
Costs
HBOT is recognized by Medicare in the United States as a reimbursable treatment for 14 UHMS "approved" conditions. A 1-hour HBOT session may cost between $300 and higher in private clinics, and over $2,000 in hospitals. U.S. physicians (M.D. or D.O.) may lawfully prescribe HBOT for "off-label" conditions such as stroke, and migraine.
Such patients are treated in outpatient clinics. In the United Kingdom most chambers are financed by the National Health Service, although some, such as those run by Multiple Sclerosis Therapy Centres, are non-profit. In Australia, HBOT is not covered by Medicare as a treatment for multiple sclerosis.
China and Russia treat more than 80 maladies, conditions, and trauma with HBOT.
Respiratory distress
People who are having extreme difficulty breathing – acute respiratory distress syndrome – are commonly given oxygen and there have been limited trials of hyperbaric equipment in such cases. Examples include treatment of the Spanish flu and COVID-19.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1373468397 under CC BY-SA 4.0; modifications have been made.
References
- ↩Wikipedia “Hyperbaric medicine” publication date (×1) · confidence 0.95 revision URL